4.5 Article

Structure-activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonists

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 20, 期 12, 页码 3573-3578

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2010.04.125

关键词

Calcium-activated potassium channel; BKCa; BKCa agonists

向作者/读者索取更多资源

The membrane bound large-conductance, calcium-activated potassium channel (BKCa) is an important regulator of neuronal activity. Here we describe the identification and structure-activity relationship of a novel class of potent tetrahydroquinoline BKCa agonists. An example from this class of BKCa agonists was shown to depress the spontaneous neuronal discharges in an electrophysiological model of migraine. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

The imidazo[1,2-a] pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors

Markian M. Stec, Kristin L. Andrews, Yunxin Bo, Sean Caenepeel, Hongyu Liao, John McCarter, Erin L. Mullady, Tisha San Miguel, Raju Subramanian, Nuria Tamayo, Douglas A. Whittington, Ling Wang, Tian Wu, Leeanne P. Zalameda, Nancy Zhang, Paul E. Hughes, Mark H. Norman

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Chemistry, Medicinal

Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational Constraint

Lewis D. Pennington, Michael D. Bartberger, Michael D. Croghan, Kristin L. Andrews, Kate S. Ashton, Matthew P. Bourbeau, Jie Chen, Samer Chmait, Rod Cupples, Christopher Fotsch, Joan Helmering, Fang-Tsao Hong, Randall W. Hungate, Steven R. Jordan, Ke Kong, Longbin Liu, Klaus Michelsen, Carolyn Moyer, Nobuko Nishimura, Mark H. Norman, Andreas Reichelt, Aaron C. Siegmund, Glenn Sivits, Seifu Tadesse, Christopher M. Tegley, Gwyneth Van, Kevin C. Yang, Guomin Yao, Jiandong Zhang, David J. Lloyd, Clarence Hale, David J. St Jean

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis

Nuria A. Tamayo, Mark H. Norman, Michael D. Bartberger, Fang-Tsao Hong, Yunxin Bo, Longbin Liu, Nobuko Nishimura, Kevin C. Yang, Seifu Tadesse, Christopher Fotsch, Jie Chen, Samer Chmait, Rod Cupples, Clarence Hale, Steven R. Jordan, David J. Lloyd, Glenn Sivits, Gwyneth Van, David J. St. Jean

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)

Adrian L. Smith, Kristin L. Andrews, Holger Beckmann, Steven F. Bellon, Pedro J. Beltran, Shon Booker, Hao Chen, Young-Ah Chung, Noel D. D'Angelo, Jennifer Dao, Kenneth R. Dellamaggiore, Peter Jaeckel, Richard Kendall, Katja Labitzke, Alexander M. Long, Silvia Materna-Reichelt, Petia Mitchell, Mark H. Norman, David Powers, Mark Rose, Paul L. Shaffer, Michelle M. Wu, J. Russell Lipford

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling

Longbin Liu, Matthew R. Lee, Joseph L. Kim, Douglas A. Whittington, Howard Bregman, Zihao Hua, Richard T. Lewis, Matthew W. Martin, Nobuko Nishimura, Michele Potashman, Kevin Yang, Shuyan Yi, Karina R. Vaida, Linda F. Epstein, Carol Babij, Manory Fernando, Josette Carnahan, Mark H. Norman

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Correction Biochemistry & Molecular Biology

Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling (vol 24, pg 2215, 2016)

Longbin Liu, Matthew R. Lee, Joseph L. Kim, Douglas A. Whittington, Howard Bregman, Zihao Hua, Richard T. Lewis, Matthew W. Martin, Nobuko Nishimura, Michele Potashman, Kevin Yang, Shuyan Yi, Karina R. Vaida, Linda F. Epstein, Carol Babij, Manory Fernando, Josette Carnahan, Mark H. Norman

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors

Liping H. Pettus, Kristin L. Andrews, Shon K. Booker, Jie Chen, Victor J. Cee, Frank Chavez, Yuping Chen, Heather Eastwood, Nadia Guerrero, Bradley Herberich, Dean Hickman, Brian A. Lanman, Jimmy Laszlo, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou, Andrew S. Tasker, Hui-Ling Wang

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 4. Exploration of a Novel Binding Pocket

Fang-Tsao Hong, Mark H. Norman, Kate S. Ashton, Michael D. Bartberger, Jie Chen, Samer Chmait, Rod Cupples, Christopher Fotsch, Steven R. Jordan, David J. Lloyd, Glenn Sivits, Seifu Tadesse, Clarence Hale, David J. St Jean

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic Profiles

David J. St Jean, Kate S. Ashton, Michael D. Bartberger, Jie Chen, Samer Chmait, Rod Cupples, Elizabeth Galbreath, Joan Helmering, Fang-Tsao Hong, Steven R. Jordan, Longbin Liu, Roxanne K. Kunz, Klaus Michelsen, Nobuko Nishimura, Lewis D. Pennington, Steve F. Poon, Darren Reid, Glenn Sivits, Markian M. Stec, Seifu Tadesse, Nuria Tamayo, Gwyneth Van, Kevin C. Yang, Jiandong Zhang, Mark H. Norman, Christopher Fotsch, David J. Lloyd, Clarence Hale

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Small Molecule Disruptors of the Glucokinase Glucokinase Regulatory Protein Interaction: 3. Structure Activity Relationships within the Aryl Carbinol Region of the N-Arylsulfonamido-N'-arylpiperazine Series

Nobuko Nishimura, Mark H. Norman, Longbin Liu, Kevin C. Yang, Kate S. Ashton, Michael D. Bartberger, Samer Chmait, Jie Chen, Rod Cupples, Christopher Fotsch, Joan Helmering, Steven R. Jordan, Roxanne K. Kunz, Lewis D. Pennington, Steve F. Poon, Aaron Siegmund, Glenn Sivits, David J. Lloyd, Clarence Hale, David J. St Jean

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists

Daniel B. Horne, Nuria A. Tamayo, Michael D. Bartberger, Yunxin Bo, Jeffrey Clarine, Carl D. Davis, Vijay K. Gore, Matthew R. Kaller, Sonya G. Lehto, Vu V. Ma, Nobuko Nishimura, Thomas T. Nguyen, Phi Tang, Weiya Wang, Beth D. Youngblood, Maosheng Zhang, Narender R. Gavva, Holger Monenschein, Mark H. Norman

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors

David J. Lloyd, David J. St Jean, Robert J. M. Kurzeja, Robert C. Wahl, Klaus Michelsen, Rod Cupples, Michelle Chen, John Wu, Glenn Sivits, Joan Helmering, Renee Komorowski, Kate S. Ashton, Lewis D. Pennington, Christopher Fotsch, Mukta Vazir, Kui Chen, Samer Chmait, Jiandong Zhang, Longbin Liu, Mark H. Norman, Kristin L. Andrews, Michael D. Bartberger, Gwyneth Van, Elizabeth J. Galbreath, Steven L. Vonderfecht, Minghan Wang, Steven R. Jordan, Murielle M. Veniant, Clarence Hale

NATURE (2013)

Article Chemistry, Organic

A general method for the facile synthesis of optically active 2-substituted piperazines via functionalized 2,5-diketopiperazines

Kate S. Ashton, Mitchell Denti, Mark H. Norman, David J. St Jean

TETRAHEDRON LETTERS (2014)

Article Toxicology

P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors

Raju Subramanian, Divesh Aidasani, Keith Bailey, Dan Branstetter, Nancy Everds, Jian Jiang, Mark H. Norman, Ronya Primack, Gary L. Skiles, Irene Soto, Markian M. Stec, Mylo Wagner, Tian Wu, Xiaochun Zhu, Herve Lebrec

TOXICOLOGICAL SCIENCES (2014)

Article Chemistry, Medicinal

Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies

Hui-Ling Wang, Kristin L. Andrews, Shon K. Booker, Jude Canon, Victor J. Cee, Frank Chavez, Yuping Chen, Heather Eastwood, Nadia Guerrero, Brad Herberich, Dean Hickman, Brian A. Lanman, Jimmy Laszlo, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, Liping H. Pettus, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Qiong Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou, Andrew S. Tasker

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)